HealthSouth Corp (HLS) Shares Sold by Magnetar Financial LLC

Magnetar Financial LLC trimmed its stake in HealthSouth Corp (NYSE:HLS) by 68.3% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 6,458 shares of the company’s stock after selling 13,888 shares during the period. Magnetar Financial LLC’s holdings in HealthSouth were worth $299,000 as of its most recent SEC filing.

Several other hedge funds also recently bought and sold shares of HLS. Strs Ohio increased its position in shares of HealthSouth by 7.5% in the second quarter. Strs Ohio now owns 14,300 shares of the company’s stock worth $692,000 after purchasing an additional 1,000 shares during the last quarter. NGAM Advisors L.P. increased its position in shares of HealthSouth by 1.4% in the second quarter. NGAM Advisors L.P. now owns 10,448 shares of the company’s stock worth $506,000 after purchasing an additional 142 shares during the last quarter. Great West Life Assurance Co. Can increased its position in shares of HealthSouth by 3.1% in the second quarter. Great West Life Assurance Co. Can now owns 53,265 shares of the company’s stock worth $2,577,000 after purchasing an additional 1,602 shares during the last quarter. Trexquant Investment LP bought a new position in shares of HealthSouth in the second quarter worth approximately $284,000. Finally, Schwab Charles Investment Management Inc. increased its position in shares of HealthSouth by 5.3% in the second quarter. Schwab Charles Investment Management Inc. now owns 671,304 shares of the company’s stock worth $32,492,000 after purchasing an additional 34,035 shares during the last quarter. Institutional investors own 93.37% of the company’s stock.

Several brokerages have issued reports on HLS. Royal Bank of Canada reaffirmed a “buy” rating on shares of HealthSouth in a research note on Wednesday, November 15th. ValuEngine lowered HealthSouth from a “buy” rating to a “hold” rating in a research note on Friday, September 1st. Mizuho raised HealthSouth from a “neutral” rating to a “buy” rating and set a $55.00 target price for the company in a research note on Thursday, November 2nd. Stephens began coverage on HealthSouth in a research note on Thursday, August 31st. They issued an “overweight” rating and a $53.00 target price for the company. Finally, Zacks Investment Research lowered HealthSouth from a “buy” rating to a “hold” rating in a research note on Tuesday, October 31st. Two analysts have rated the stock with a sell rating, four have assigned a hold rating and six have assigned a buy rating to the company. HealthSouth presently has an average rating of “Hold” and a consensus target price of $51.75.

In related news, Director Yvonne M. Curl acquired 1,000 shares of the company’s stock in a transaction dated Wednesday, November 1st. The stock was purchased at an average price of $45.95 per share, with a total value of $45,950.00. Following the completion of the purchase, the director now owns 64,144 shares in the company, valued at approximately $2,947,416.80. The acquisition was disclosed in a filing with the SEC, which can be accessed through this link. Corporate insiders own 1.60% of the company’s stock.

Shares of HealthSouth Corp (NYSE HLS) opened at $50.10 on Friday. The stock has a market capitalization of $4,856.55, a P/E ratio of 17.71, a price-to-earnings-growth ratio of 1.82 and a beta of 0.54. The company has a debt-to-equity ratio of 1.89, a current ratio of 1.34 and a quick ratio of 1.34. HealthSouth Corp has a 52 week low of $38.24 and a 52 week high of $50.41.

HealthSouth (NYSE:HLS) last issued its earnings results on Thursday, October 26th. The company reported $0.66 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.65 by $0.01. The business had revenue of $995.60 million during the quarter, compared to analyst estimates of $985.75 million. HealthSouth had a return on equity of 22.81% and a net margin of 6.69%. HealthSouth’s revenue for the quarter was up 7.4% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.65 earnings per share. equities analysts expect that HealthSouth Corp will post 2.72 EPS for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, January 16th. Stockholders of record on Tuesday, January 2nd will be paid a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a dividend yield of 2.00%. The ex-dividend date of this dividend is Friday, December 29th. HealthSouth’s dividend payout ratio (DPR) is presently 36.36%.

WARNING: This piece of content was originally published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this piece of content on another publication, it was illegally stolen and republished in violation of US & international trademark & copyright legislation. The original version of this piece of content can be viewed at https://www.dispatchtribunal.com/2017/12/16/healthsouth-corp-hls-shares-sold-by-magnetar-financial-llc.html.

HealthSouth Profile

HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company manages its operations through segments, including inpatient rehabilitation, and home health and hospice.

Institutional Ownership by Quarter for HealthSouth (NYSE:HLS)

Receive News & Ratings for HealthSouth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthSouth and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply